ANTARES PHARMA INC's ticker is and the CUSIP is 036642906. A total of 3 filers reported holding ANTARES PHARMA INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $60,000 | +2900.0% | 17,000 | +2733.3% | 0.00% | – |
| Q3 2021 | $2,000 | -98.5% | 600 | +87.5% | 0.00% | – |
| Q1 2021 | $131,000 | -19.1% | 320 | -21.4% | 0.00% | – |
| Q4 2020 | $162,000 | +40.9% | 407 | -5.1% | 0.00% | – |
| Q3 2020 | $115,000 | +11.7% | 429 | +14.4% | 0.00% | – |
| Q2 2020 | $103,000 | +37.3% | 375 | +17.9% | 0.00% | – |
| Q1 2020 | $75,000 | -25.0% | 318 | +48.6% | 0.00% | – |
| Q4 2019 | $100,000 | +156.4% | 214 | +79.8% | 0.00% | – |
| Q3 2019 | $39,000 | -61.4% | 119 | -61.2% | 0.00% | – |
| Q2 2019 | $101,000 | -24.6% | 307 | -30.9% | 0.00% | – |
| Q1 2019 | $134,000 | +1575.0% | 444 | +1245.5% | 0.00% | – |
| Q4 2018 | $8,000 | -66.7% | 33 | -54.8% | 0.00% | – |
| Q3 2018 | $24,000 | +84.6% | 73 | +37.7% | 0.00% | – |
| Q2 2018 | $13,000 | – | 53 | +60.6% | 0.00% | – |
| Q1 2018 | $0 | – | 33 | +1550.0% | 0.00% | – |
| Q4 2017 | $0 | – | 2 | -86.7% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 15 | -84.2% | 0.00% | – |
| Q2 2017 | $2,000 | 0.0% | 95 | +8.0% | 0.00% | – |
| Q1 2017 | $2,000 | -75.0% | 88 | -77.4% | 0.00% | – |
| Q4 2016 | $8,000 | +60.0% | 389 | +12.1% | 0.00% | – |
| Q3 2016 | $5,000 | – | 347 | +1477.3% | 0.00% | – |
| Q2 2016 | $0 | – | 22 | +2100.0% | 0.00% | – |
| Q3 2015 | $0 | – | 1 | -66.7% | 0.00% | – |
| Q2 2015 | $0 | – | 3 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|